Emerging therapeutics in idiopathic inflammatory myopathy
Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of systemic autoimmune diseases characterized mainly by inflammation of muscle tissue. Although IIM traditionally encompasses polymyositis, dermatomyositis (DM), and inclusion body myositis, the disease concept has been changing in...
Saved in:
Main Author: | Shinji Sato |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=6;spage=153;epage=162;aulast=Sato |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The utility of muscle magnetic resonance imaging in idiopathic inflammatory myopathies: a scoping review
by: Julie J. Paik, et al.
Published: (2025-01-01) -
Development of the myocite biobank: Cost-efficient model of public sector investigator-driven biobank for idiopathic inflammatory myositis
by: R Naveen, et al.
Published: (2020-01-01) -
Picking interstitial lung disease out of the myositis haystack
by: Jennifer Hannah, et al.
Published: (2020-01-01) -
Ultrasensitive interferons quantification reveals different cytokine profile secretion in inflammatory myopathies and can serve as biomarkers of activity in dermatomyositis
by: Loïs Bolko, et al.
Published: (2025-02-01) -
Clinical characteristics and prognosis of amyopathic dermatomyositis patients with interstitial lung disease: insights from a retrospective cohort
by: Yanan Ying, et al.
Published: (2025-02-01)